p<0.0005) (Fig 2) .
Eosinophils: Regression analysis showed there was a significant dose-related suppression of eosinophils with prednisolone (p<0.001) but not with budes¬ onide (Fig 1) . There were significant differences from placebo with medium and high doses of pred¬ nisolone (p<0.05) but not with any dose of budes¬ onide. There were significant differences between the two drugs only at the highest dose level, amount¬ ing to a 1.87-fold difference (95% CI, 1.16 to 3.00).
Osteocalcin: Regression analysis showed there was a significant dose-related suppression of osteocalcin with prednisolone (p<0.05) but not with budesonide (Fig 1) . There were significant differences from placebo for medium and high doses of prednisolone (p<0.05) but not for any dose of budesonide. There were significant differences between the two drugs at the medium-and high-dose levels. At blood eosinophils, and serum osteocalcin). 
